Sarepta Partners with StrideBio

November 26, 2019

Sarepta Partners with StrideBio

Sarepta has given StrideBio, a company with expertise in adeno-associated viruses and capsids, a license to research, develop and manufacture up to eight gene therapies. "With our partnership with StrideBio, Sarepta continues to build on its leadership position in gene therapies to treat rare diseases," said Doug Ingram, CEO. Yourway provides services for cell and gene therapy companies, and has the regulatory expertise needed to support these therapies globally.

Back to Index

Media

Upcoming Event

IQPC CTS

August 24-26, 2020
Brussels, Belgium

Schedule a Meeting

Media

Articles

The New Normal in Clinical Trial Protection

Open chat

Hello! How can I help you?